Rockwell Medical Inc

NASDAQ:RMTI   3:59:55 PM EDT
0.92
+0.04 (+4.82%)
Products

Rockwell Medical And Drogsan Pharmaceuticals Enter Into Exclusive License Agreement For The Rights To Commercialize Triferic In Turkey

Published: 06/08/2021 11:39 GMT
Rockwell Medical Inc (RMTI) - Rockwell Medical and Drogsan Pharmaceuticals Enter Into Exclusive License Agreement for the Rights to Commercialize Triferic® in Turkey.
Rockwell Medical - Drogsan Will Be Exclusive Development, Commercialization Partner for Triferic in Turkey, Co Will Supply Product to Drogsan.
Rockwell Medical Inc - Agreement Allows for Drogsan to Negotiate Further Geographic Expansion Into Surrounding Region.
Rockwell - in Consideration for License, Will Receive an Upfront Fee, Will Be Eligible for Milestone Payments Based on Reimbursement Price Approval.